Long, Noncoding RNA Dysregulation in Glioblastoma

SIMPLE SUMMARY: Developing effective therapies for glioblastoma (GBM), the most common primary brain cancer, remains challenging due to the heterogeneity within tumors and therapeutic resistance that drives recurrence. Noncoding RNAs are transcribed from a large proportion of the genome and remain l...

Descripción completa

Detalles Bibliográficos
Autores principales: DeSouza, Patrick A., Qu, Xuan, Chen, Hao, Patel, Bhuvic, Maher, Christopher A., Kim, Albert H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037018/
https://www.ncbi.nlm.nih.gov/pubmed/33807183
http://dx.doi.org/10.3390/cancers13071604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037018/
https://www.ncbi.nlm.nih.gov/pubmed/33807183
http://dx.doi.org/10.3390/cancers13071604

Ejemplares similares